Stanford Cancer Imaging Training (SCIT) Program

Leadership

Program Directors



Steering Committee

Drs. Napel and Sommer will initially appoint the Steering Committee (SC), which consists of themselves and 4 Program Faculty, who will serve for two years. Appointments will be made after the program is renewed for 2013.


Advisory Committee

We have assembled an outstanding Advisory Committee, which meets annually, consisting of both Stanford faculty and external advisors.

Sam Gambhir, MD, PhD Sanjiv Sam Gambhir, MD, PhD
Professor and Chair of the Department of Radiology
Professor of Bioengineering and Materials Science & Engineering (by courtesy)
Director of the Molecular Imaging Program at Stanford (MIPS)
Director of the Canary Center at Stanford for Cancer Early Detection

Dr. Gambhir is world-renowned for his contributions to cancer imaging. He brings this experience, as well as that from having directed several training programs, including a multidisciplinary R25T (Stanford Molecular Imaging Scholars (SMIS). He also provides important links to clinical programs in oncological imaging research.

Gary Glover, PhD
Professor of Radiology, Neurosciences & Biophysics
Professor of Electrical Engineering and Psychology (by courtesy)
Director, Radiological Sciences Laboratory

Dr. Glover is a leading expert in MR imaging and its applications. In addition, he brings almost 20 years of experience in this T32 training program, and management experience from directing the Radiological Sciences Laboratory and a large NCRR Research Resource funded via the P41 mechanism, the Center for Advanced Magnetic Resonance Technology (CAMRT) at Stanford.

Susan Knox, MD
Associate Professor of Radiation Oncology - Radiation Therapy

Dr. Knox specializes in cancer therapy, specifically radioimmunotherapy, and has been on the Advisory Committee for 11 years. She has been of great service to our program, providing a vital link to the needs on the therapy side of cancer imaging. Dr. Knox also has several years of experience leading clinical trials. Through her experience as PI and mentor for clinical trials she will be able to advise, in particular, in areas of translational research.

Norbert Pelc, ScD
Professor of Radiology and Bioengineering

He has been active in diagnostic imaging research for more than 35 years, having made major contributions to CT, MR, ultrasound, x-ray, and nuclear medicine imaging. He has almost 20 years of experience in this T32 training program, and has mentored many pre- and postdoctoral fellows, many of whom have gone on to successful careers in academia and industry. In addition, he leads a T32 (Training In Biomedical Imaging Instrumentation - TBI2) that focuses on pre-doctoral training.

Hannah Valantine, MD
Professor of Cardiovascular Medicine
Senior Associate Dean for Diversity and Faculty Development in the School of Medicine

She not only brings her personal experience mentoring a diverse set of students, but also, as Associate Dean, she is committed to fostering diversity in the academic workforce. Her office has a focused agenda and a host of tools for increasing diversity in graduate programs and the faculty. Dr. Valentine will join our Advisory Committee this year and will directly advise our new Diversity Officer, Dr. Sommer, to assist us in achieving our diversity goals within the SCIT program.

Michael McNitt-Gray, PhD
Professor of Radiology, David Geffen School Medicine at UCLA

Dr. McNitt-Gray will be an external member of the Advisory Committee. He brings his experience as the Program Director of the UCLA Biomedical Physics Graduate Program, an interdisciplinary program supported for over 35 years with an NIH T32 training grant. He has also devoted much of his research career to understanding and improving the detection of lung cancer using imaging.

John Gore, PhD
Professor of Molecular Physiology and Biophysics
Radiology and Radiological Sciences
Biomedical Engineering and Physics and Astronomy
Vanderbilt University Institute of Imaging Science

Dr. Gore will be an external member of the Advisory Committee. He brings experience directing both R25T and T32 NCI supported Training Programs, and has been active in the development of imaging methods for over 35 years, more recently focusing on the development of imaging biomarkers in cancer.

Stanford Medicine Resources:

Footer Links: